FDA cleared Tregzi to improve chronic GVHD-free survival, representing a non-pharmacologic strategy to reduce chronic GVHD while supporting immune reconstitution after allogeneic transplantation.
Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, it only activates when it detects a precise combination of ...
Meet the Class of 2026 valedictorians and salutatorians from Seminole County high schools. Editor’s note: The Sentinel has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results